NCT01199224View on ClinicalTrials.gov

To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Solid Tumors
Interventions
DRUG

veliparib

veliparib formulation A

DRUG

veliparib

veliparib formulation B

DRUG

veliparib

veliparib formulation C

DRUG

veliparib

veliparib formulation C

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY